Individualized vs High-Calorie Refeeding for Anorexia Nervosa
(i-STRONG Trial)
Trial Summary
What is the purpose of this trial?
The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Higher Calorie Refeeding (HCR) for Anorexia Nervosa?
Research shows that Higher Calorie Refeeding (HCR) can help patients with anorexia nervosa gain weight faster and leave the hospital sooner without increasing the risk of refeeding syndrome, a serious condition that can occur when feeding is restarted after malnutrition. Studies also suggest that HCR is safe and effective for children and adolescents with anorexia nervosa, even for those with very low body weight.12345
Is higher calorie refeeding safe for humans?
How does the treatment for anorexia nervosa differ from other treatments?
The treatment for anorexia nervosa using higher calorie refeeding (HCR) is unique because it involves starting with a higher calorie intake to restore weight and medical stability faster, compared to the traditional approach of starting with lower calories and increasing slowly. This method has been shown to shorten hospital stays and improve initial weight gain without increasing the risk of refeeding syndrome, a serious condition that can occur when feeding is restarted after malnutrition.24567
Research Team
Andrea K Garber, RD, PhD
Principal Investigator
University of California, San Francisco
Neville H Golden, MD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for hospitalized youths aged 12-24 with atypical anorexia nervosa, who meet specific health criteria like low heart rate or blood pressure. It's not for those with bulimia, recent refeeding hospital stays, chronic diseases, pregnancy, or acute mental health crises.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are hospitalized and receive either Individualized Caloric Refeeding (ICR) or Higher Calorie Refeeding (HCR) to achieve medical stability
Follow-up
Participants are monitored for metabolic, hormonal, and psychological markers to develop a definition of clinical remission in AAN
Treatment Details
Interventions
- Higher Calorie Refeeding (HCR)
- Individualized Caloric Refeeding (ICR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Stanford University
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator